Source: Health policy. Unidade: FCF
Subjects: DOENÇAS RARAS, MEDICAMENTO
ABNT
FELIPPINI, Arturo et al. HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review. Health policy, v. 144, p. 1-8 art. 105080, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.healthpol.2024.105080. Acesso em: 15 jun. 2024.APA
Felippini, A., Biglia, L. V., Lima, T. de M., & Aguiar, P. M. (2024). HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review. Health policy, 144, 1-8 art. 105080. doi:10.1016/j.healthpol.2024.105080NLM
Felippini A, Biglia LV, Lima T de M, Aguiar PM. HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review [Internet]. Health policy. 2024 ; 144 1-8 art. 105080.[citado 2024 jun. 15 ] Available from: https://dx.doi.org/10.1016/j.healthpol.2024.105080Vancouver
Felippini A, Biglia LV, Lima T de M, Aguiar PM. HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review [Internet]. Health policy. 2024 ; 144 1-8 art. 105080.[citado 2024 jun. 15 ] Available from: https://dx.doi.org/10.1016/j.healthpol.2024.105080